Language barrier means millions of elderly can't access Alzheimer's trials
NPR
in this NPR Op-Ed, Josh Eibelman '20 describes how millions of individuals suffering from Alzheimers that are not fluent in English are barred from participating in clinical trials to treat Alzheimers.